New Products Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Products Watch.

Press releases published on April 17, 2026

ALDX SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Aldeyra Therapeutics Investors - Contact Kirby McInerney LLP by May 29, 2026
Suunto Spark brings air-conduction technology to Suunto's headphones
Flixy Smart TV Stick Claims Evaluated: The Most Recommended TV Streaming Stick Device Without Costly Subscriptions
Rally House Expands Triangle Presence with Cary Location
Mannatech Reports Financial Results for Fourth Quarter and Year Ended 2025
Arbe Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
ZSPC Investor News: If You Have Suffered Losses in zSpace Inc. (NASDAQ: ZSPC), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
Sow Good Inc. Announces Reverse Stock Split
Keeps Hair Growth Product Claims Evaluated: Topical & Oral RX Hair Loss Prescription Treatment with Finasteride, Dutasteride & Minoxidil
LGI Homes Expands in the Salt Lake City Market with Grand Opening of Desert Edge
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
CAPHRA: Making NRTs Harder to Get is Public Health Madness
Sysco Declares Increase to Quarterly Dividend Payment
Top Pendant Light Manufacturers Leading Innovation in Modern Lighting Design
Lincoln Educational Services Corporation Schedules First Quarter 2026 Earnings Release And Conference Call
Vera Bradley Terminates Existing Shareholder Rights Plan
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of Rinzimetostat Across Prostate Cancer and in Emerging Resistance Settings at the 2026 American Association for Cancer Research (AACR) Annual Meeting
Adagene Presents Two Posters at AACR 2026 with New Data Highlighting Muzastotug’s Potential as a Backbone Combination Therapy for Multiple Tumor Types
Cardiff Oncology Presents Preclinical Data on its PLK1 Inhibitor Onvansertib in Combination with a HER2-Targeted ADC at the 2026 AACR Annual Meeting

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

New Products Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.